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Exposure to environmental contaminants during pregnancy has been linked to adverse 
outcomes at birth and later in life. The link between prenatal exposures and latent 
health outcomes suggests that these exposures may result in long-term epigenetic 
reprogramming. Toxic metals and endocrine disruptors are two major classes of 
contaminants that are ubiquitously present in the environment and represent threats 
to human health. In this review, we present evidence that prenatal exposures to 
these contaminants result in fetal epigenomic changes, including altered global DNA 
methylation, gene-specific CpG methylation and microRNA expression. Importantly, 
these changes may have functional cellular consequences, impacting health outcomes 
later in life. Therefore, these epigenetic changes represent a critical mechanism that 
warrants further study.
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The fetal epigenome represents a critical 
developmental target, as epigenetic modi-
fications are thought to underlie a range of 
disease outcomes, from cancer to neurode-
velopmental disease [1,2]. There is increasing 
evidence that epigenetic reprogramming in 
early life may persist, influencing both devel-
opment and susceptibility to disease later in 
life. In relation to the prenatal period, expo-
sures are of particular concern as this time 
frame represents a susceptible developmental 
window during which critical patterns of 
DNA methylation and gene expression are 
being established [1]. Evidence that exposures 
during the prenatal period may result in epi-
genetic alterations supports the Developmen-
tal Origins of Health and Disease (DOHaD) 
hypothesis. This hypothesis, originally pro-
posed by David Barker, posits that condi-
tions experienced in utero play a role in fetal 
programming with important consequences 
for later life outcomes [3–5]. Critically, epi-
genetic modifications, particularly CpG 
methylation, are responsive to environmen-
tal factors, allowing these exposures to leave 
‘ environmental footprints’ on DNA [6–9].
There are three major forms of epigenetic 
modifications, namely DNA methylation, 
microRNA (miRNA) expression, and his-
tone modifications [10]. This review focuses 
primarily on two of these modifications, 
namely, DNA methylation and miRNAs. 
Briefly, DNA methylation involves ‘tag-
ging’ nucleotide bases with methyl groups, 
particularly at the 5′ position of cytosine 
(5′-mC). Depending on the genomic loca-
tion, such methylation can either activate or 
silence transcription. A proposed mechanism 
by which this occurs is via transcription fac-
tor binding to DNA. In contrast, miRNAs 
are short, nontranslated RNAs that bind 
to and inhibit translation of mRNAs with 
reciprocal sequences [11,12]. Notably, these 
epigenetic modifications may ‘cross-talk’ 
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with one another. For instance, evidence suggests that 
there is a relationship between DNA methylation and 
histone modifications, such that sites of histone modi-
fications and DNA methylation are highly associated 
with one another [13]. Additionally, experimental evi-
dence has demonstrated that manipulating histone 
acetylation induces alterations in DNA methylation, 
and vice versa [14,15]. Together, these epigenetic regula-
tors control the timing and level of gene expression, 
f undamentally controlling cellular and physiologic 
function.
Toxic metals and endocrine disruptors are ubiqui-
tously found in the environment and have been mea-
sured and quantified in the fetus, supporting that in 
utero exposure to these chemicals occurs [16,17]. Given 
the link between prenatal exposures to toxic metals, 
endocrine disruptors and diseases occurring later in 
life, epigenetic modifications are believed, at least in 
part, to underlie these effects [18]. This review summa-
rizes the current literature related to four toxic met-
als where prenatal exposure is common and early life 
exposure yields both early developmental and later 
life effects, namely arsenic (As), cadmium (Cd), lead 
(Pb) and mercury (Hg). It also details studies related 
to five endocrine disruptors, specifically bisphenol-A 
(BPA), dichlorodiphenyltrichloroethane (DDT), poly-
brominated diphenyl ethers (PBDE), polychlorinated 
biphenyls (PCB) and phthalates. This review provides 
an overview of existing research that explores the rela-
tionship between prenatal exposure to both metals and 
endocrine disruptors in relation to the fetal epigenome, 
along with connections between observed epigenetic 
reprogramming and adverse health outcomes.
Toxic metals
Toxic metals, in contrast to essential metals, are those 
that are harmful to human health. For the toxic met-
als reviewed here, there is substantive literature link-
ing early life exposures to persistent adverse health 
effects. In the following section, we summarize studies 
detailing the relationship between prenatal exposure 
to four toxic metals – As, Cd, Pb and Hg – and the 
fetal epigenome. Notably, all of the toxic metals dis-
cussed are known to cross the placental barrier, to some 
extent [19–21]. This suggests that the placenta serves as 
an incomplete barrier, resulting in direct fetal exposure 
to these compounds. The studies detailed below are 
summarized in Supplementary Table 1.
Arsenic
Inorganic arsenic (iAs) is a toxic metalloid ubiquitous 
in the environment with exposure related to both can-
cer and noncancer end points [22]. Notably, exposure 
via contaminated drinking water is a major route of 
concern. More than 100 million people are at risk of 
exposure that exceeds the World Health Organization’s 
recommended limit of 10 parts per billion (ppb) [22]. 
iAs and its methylated metabolites are known to cross 
the placenta and are found within cord blood at similar 
levels as those in the mother [19]. Prenatal iAs exposure 
is linked to a wide range of adverse health outcomes 
that may be present at birth or those that emerge later 
in life, the latter suggesting long-term epigenomic 
reprogramming of the fetus [23]. It has been hypoth-
esized that iAs impacts DNA methylation by creating 
competition for methyl donors, leading to dysregula-
tion of DNA methylation processes [24,25]. However, 
this theory cannot account for the observation of gene-
specific methylation patterns following iAs exposure. 
Instead, a separate hypothesis suggests that iAs, and 
other environmental contaminants, may disrupt tran-
scription factor occupancy, including access of the 
methylation machinery to areas of the genome, giving 
rise to gene-specific patterning of CpG methylation [9].
The relationship between prenatal iAs exposure and 
global DNA methylation has been examined in several 
different populations, including those in Bangladesh, 
Mexico and the USA. Global methylation is often mea-
sured by examining methylation at CpG sites located 
within transposable elements, such as LINE1 or Alu, 
which comprise up to 30% of the human genome [26]. 
Changes in global hypomethylation are of concern as 
it is thought to create genomic instability, yielding an 
environment in which mutations may arise from the 
activities of transposable elements or where tumor-
promoting genes may be overexpressed. In Bangladesh, 
where iAs exposures can range up to 2.5 parts per mil-
lion (ppm), mixed results have been noted with respect 
to LINE1 methylation and no relationships have been 
noted between iAs exposure and luminometric meth-
ylation assay (LUMA) methylation or Alu methyla-
tion [22,27–29]. Similarly, results from an exposed popu-
lation in Thailand indicate no relationship between 
cord blood LINE1 methylation and iAs exposure [30]. 
However, results from a Bangladesh-based nutritional 
intervention suggest a sex-dependent effect of maternal 
urinary As on cord blood methylation, noting nonsig-
nificant hypermethylation in Alu, LINE1 and LUMA 
methylation in males, but hypomethylation in females. 
Results from this same study have also reported a 
positive association between maternal urinary total 
As and global methylation of cord blood, measured 
using a methyl incorporation assay [29]. These results 
suggest that impact of prenatal iAs exposure on global 
 methylation may depend on fetal sex.
Numerous studies have also examined the relation-
ship between prenatal iAs exposure and methylation of 
gene-specific regions of DNA. Targeted gene analyses 
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have identified differential methylation of p16 and p53 
promoter regions, providing evidence that iAs dys-
regulates critical tumor suppressor pathways in cord 
blood [27,30]. Several studies examining genome-wide 
methylation have reported few differentially methyl-
ated CpG sites following false discovery rate correc-
tion [28,31,32]. However, among the most significant 
probes identified in these analyses, enrichment for 
genes involved in pathways related to juvenile dia-
betes, cancers, infectious diseases and inflammatory 
disorders has been noted, providing evidence, at the 
molecular level, for the relationship between prenatal 
iAs exposure and such outcomes [28,32]. Yet, other stud-
ies have identified more robust changes in the newborn 
epigenome. For instance, research from the Biomark-
ers of Exposure to ARsenic (BEAR) pregnancy cohort 
in Mexico identified over 2000 differentially meth-
ylated CpG sites. Methylation for a set of these was 
functional, predicting altered gene expression in the 
cord blood as well as showing an association with birth 
outcomes. Notably, among the genes identified was the 
imprinted gene KCNQ1 [8]. When considering meth-
ylation changes across a variety of fetal tissues, Carde-
nas et al. identified numerous differentially methylated 
genes associated with iAs in the placenta and umbili-
cal artery. In particular, the genes identified here were 
enriched for pathways similar to those noted above, 
reinforcing these previous observations [33]. Similarly, 
while a recent study from the New Hampshire Birth 
Cohort did not find significant relationships between 
maternal urinary total As and placental methylation, 
and only one significant probe when considering mater-
nal toenail iAs, they reported over 100 differentially 
methylated CpG sites in the placenta associated with 
placental As [34]. Taken together, these results suggest 
that there are tissue-specific effects of iAs exposure on 
the fetal epigenome. Moreover, the effects of iAs expo-
sure vary across individuals and populations, likely as 
a result of genotype and/or nutritional factors [35,36]. 
Future research should investigate whether differen-
tial susceptibility to iAs is linked to the epigenome, 
contributing to the differences observed between the 
various Bangaldeshi, Mexican and USA populations.
As observed with studies focusing on global DNA 
methylation, sex-based differences have also been noted 
for gene-specific methylation. In particular, increas-
ing iAs exposure in male infants was more strongly 
associated with cord blood CpG methylation than in 
females. Moreover, iAs exposure in males was associ-
ated with DNA hypomethylation, while female infants 
tended to display hypermethylation. Pathway analysis 
of the most significantly affected genes also revealed 
that male infants displayed gene-specific methyla-
tion at sites that were most significantly enriched for 
cancer pathways, while females were most signifi-
cantly enriched for inflammatory diseases [28]. Future 
research should be carried out to further elucidate the 
mechanistic underpinnings of sex-based differences in 
iAs-induced disease.
Two studies have examined the relationship 
between prenatal iAs exposure and miRNA expression 
in the placenta. Research from the formerly established 
National Children’s Study (NCS), a prospective cohort 
of children across the US, did not note a relationship 
between placental iAs and miRNA expression [37]. In 
contrast, results from the BEAR cohort included dif-
ferential expression of miRNAs that mediate signaling 
pathways related to iAs-associated diseases, including 
cancer, inflammatory disease, respiratory disease and 
metabolic disease, among others [38]. Moreover, these 
miRNAs were predicted to target 20% of the observed 
differential mRNA expression in this population, indi-
cating that iAs-associated miRNA dysregulation may 
have functional consequences for downstream gene 
expression that may be related to disease outcomes [38].
Cadmium
Cd is found in the environment both as a natural com-
ponent of the earth’s crust and as a result of anthropo-
genic activities. Specifically, Cd may be found in bat-
teries, electronic waste, pesticides and tobacco smoke, 
among other sources [39]. Cd emissions have been 
declining globally, although areas of concern remain 
near smelters, e-waste sites, and other areas polluted by 
industry [39]. While Cd crosses the placenta, it does not 
cross as readily as other toxic metals because metallo-
thionein sequesters Cd within the placenta. There-
fore, the placenta provides a partial barrier against 
this metal [20]. As a result, Cd levels in cord blood are 
typically lower than maternal Cd levels [40]. Neverthe-
less, in utero Cd exposure has been linked to a range 
of adverse health effects, including impaired growth 
and neurodevelopment [41–43]. To date, one study has 
examined the relationship between global DNA meth-
ylation and prenatal Cd exposure. Boeke et al. dem-
onstrated that there is an inverse relationship between 
maternal Cd exposure and LINE1 methylation in cord 
blood [44]. These observations have also been made 
in adult populations, suggesting that similar changes 
could be occurring within fetuses following prenatal 
Cd exposure [45].
In a nested cohort from the Center for Environ-
mental Health Initiative (CEHI) Healthy Pregnancy, 
Healthy Baby study in North Carolina, DNA meth-
ylation occurring within gene-specific regions of cord 
blood DNA was examined in relationship to maternal 
blood Cd collected at delivery [7]. Over 60 genes were 
identified as differentially methylated, with a major-
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ity of them exhibiting hypermethylation. Overlap 
between differentially methylated genes identified 
within the cord blood and within maternal blood were 
also observed [7]. Taken together with the relation-
ship between Cd and global methylation, these results 
suggest that prenatal Cd exposure is associated with 
both global hypomethylation and gene-specific hyper-
methylation. However, in the Maternal and Infant 
Nutrition Interventions, Matlab (MINIMat) cohort 
in Bangladesh, no CpG sites were identified as signifi-
cant following multiple test corrections [46]. Instead, 
sex-specific effects were noted with the most signifi-
cant probes displaying hypermethylation in males, but 
hypomethylation in females. Interestingly, in girls, the 
most significant probes were enriched for genes relating 
to bone mineralization and morphology, possibly shed-
ding light on the sex-specific effects of Cd exposure, 
especially as it relates to the susceptibility of female 
populations to Cd-induced bone outcomes [46]. Other 
studies on Cd-associated fetal epigenomic alterations 
have also observed sex-specific effects [47,48]. Of note, 
the relationship between maternal blood Cd and the 
methylation of imprinted genes was altered in a sex-
dependent manner in infants from the Newborn Epi-
genetic STudy (NEST) in North Carolina [47]. These 
relationships were also dependent on levels of circulat-
ing zinc and iron, indicating that Cd-associated epig-
enomic disruptions may be modified by maternal levels 
of essential metals.
Lastly, several studies have reported on Cd-induced 
miRNA dysregulation. Placental Cd levels were sig-
nificantly associated with increased placental expres-
sion of miR-1537 [37]. Little is known about this 
miRNA, however, it has been suggested to play a role 
in cancer [49,50]. Interestingly, a recent study examin-
ing the relationship between preeclampsia and Cd 
exposure identified a set of miRNAs common to both 
preeclampsia and Cd-exposure. These miRNAs also 
regulate genes involved in the TGF-β signaling path-
way [51]. Given the epidemiological links between pla-
cental Cd levels and preeclampsia, these results pro-
vide evidence, at the molecular level, for a relationship 
between exposure and disease [52].
Lead
As observed with the ongoing struggles in Flint, 
Michigan, Pb continues to be a toxic metal of criti-
cal importance in children’s health [53,54]. In urban 
centers, children are often exposed via Pb-based paint 
that remains in homes, particularly within low socio-
economic areas [55]. However, maternal exposure is also 
of importance as Pb is known to cross the placenta, 
although the mechanisms underlying placental trans-
fer remain unknown [20]. While exposures have gener-
ally been decreasing over the course of the last century, 
even levels below the established regulatory limits (5 
μg/dL) have been associated with impaired neurode-
velopment in children [56,57]. Given the latent and per-
sistent effects of early life exposure to Pb, epigenetic 
reprogramming has been posited to contribute to these 
effects. Maternal bone Pb levels have been significantly 
associated with LINE1 and Alu methylation, although 
cord blood Pb has not [58,59]. Maternal bone Pb rep-
resents cumulative exposure, suggesting that mater-
nal cumulative Pb exposure is associated with altered 
global methylation. Supporting these observations, it 
has been previously noted that maternal bone Pb is 
better at predicting adverse health outcomes in infants 
and children than cord blood Pb [60].
In genic regions, results from the Early Life Exposures 
in Mexico to Environmental Toxicants (ELEMENT) 
study suggest that methylation of the imprinted genes 
IGF2 and HSD11B2 was positively associated with in 
utero Pb exposure, with a sex-dependent effect and 
stronger relationship in girls. However, results were not 
significant following multiple test correction [59]. Addi-
tional studies have focused on the sex-specific effects of 
Pb-induced epigenetic disruptions of the fetus. Using 
cord blood and blood spots, Sen et al. examined dif-
ferentially methylated regions of the genome that may 
serve as sex-dependent or independent biomarkers of 
Pb exposure [61,62]. Interestingly, different patterns 
were noted when observing CpG methylation in cord 
blood versus infant blood spots. In cord blood, males 
showed a greater number of sites with altered CpG 
methylation [61]. However, in blood spots, females 
showed greater disruption in CpG methylation. Given 
that males tend to be more susceptible to the effects 
of Pb exposure, researchers concluded that disruptions 
in CpG methylation may be adaptive in blood [62]. 
Notably, Sen et al. has also reported that maternal Pb 
exposure induces epigenetic changes in the germ line 
of their offspring, impacting DNA methylation in the 
F2 in humans. These results provide evidence that Pb 
exposure may induce  multigenerational epigenomic 
changes [63].
In the NCS, placental Pb levels were negatively asso-
ciated with expression of several miRNAs, including 
miR-190b [37]. Interestingly, miR-190b targets several 
neurotrophins, including NRG3, which is related to 
impulsivity. In mice, miR-190b expression is positively 
associated with impulsivity behaviors, a behavioral trait 
that has also been associated with Pb exposure [64]. 
Taken together, this suggests that Pb-associated 
miRNA changes in the placenta may relate to the 
neurological effects seen in developing children by 
targeting neurodevelopmentally- and  behavior-related 
signaling pathways.
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Mercury
Long known to be linked to adverse neurological out-
comes, Hg exposure during pregnancy is associated 
with impaired attention, visuospatial and motor func-
tioning, among other outcomes [65]. Within the US, 
approximately 15% of childbearing-age women have 
elevated blood Hg levels of concern, suggesting that 
over 600,000 children may be born with increased risks 
of such neurological outcomes [66]. Importantly, Hg 
bioaccumulates within the fetus, suggesting an active 
transport mechanism across the placenta, although the 
mechanisms for such transport are unknown [21]. No 
studies were identified that examined the relationship 
between prenatal exposures to Hg and global DNA 
methylation. However, two studies from birth cohorts 
in the USA have explored the relationship between 
in utero Hg exposure and gene-specific methylation 
in cord blood. Using independent test and validation 
populations, the relationship between cord blood Hg 
and CpG methylation was examined using several dif-
ferent methods [67]. It was shown that TCEANC2 was 
significantly differentially methylated in both the test 
and validation populations. However, given the associ-
ation between TCEANC2 and blood cell composition, 
these results could be attributed to either Hg-induced 
changes in methylation at that loci or Hg-induced 
changes in blood cell composition [67]. Therefore, these 
observations should be interpreted with caution. In a 
second study, prenatal Hg exposure was significantly 
associated with genome-wide CpG methylation, with 
a majority of significant probes displaying a nonmono-
tonic relationship between exposure and methylation. 
Notably, a subset of the Hg-associated probes were 
also significantly associated with high-risk status for 
adverse neurobehavioral outcomes, indicating that 
dysregulated CpG methylation may have functional 
consequence for Hg-associated outcomes [68].
Lastly, results from the NCS indicate that placen-
tal Hg levels are significantly associated with changes 
in miRNA expression in the placenta. In particular, 
Hg levels were associated with a large number of miR-
NAs within the let-7 family, which is critical for proper 
developmental timing in animal models [69]. Further 
examination of the relationship between let-7 miRNAs 
and Hg exposure may shed further light on the terato-
genic and other developmental effects of prenatal and 
early life Hg exposure.
Endocrine disruptors
Early life exposure to endocrine disruptors, which 
interfere with endocrine signaling and development, 
remains a topic of concern. Endocrine disruptors are 
ubiquitous in the environment, representing a wide 
range of chemicals, such as pesticides, plasticizers or 
other synthetic compounds used in industrial settings. 
While we have separated metals and endocrine disrup-
tors in this review, it is important to note that some 
toxic metals also act as endocrine disruptors [70]. In 
the following section, the literature focusing on the 
relationship between prenatal exposure to five endo-
crine disruptors and the fetal epigenome is reviewed. 
Specifically, exposures to BPA, DDT, PBDE, PCB 
and phthalates are highlighted. As noted above with 
respect to toxic metals, all of the endocrine disruptors 
discussed here are known to cross the placental bar-
rier [71–74]. The studies detailed below are summarized 
in Supplementary Table 2.
Bisphenol-A
BPA, an industrial compound with significant estro-
genic effects, is used in a variety of products as a com-
ponent of polycarbonate plastics or epoxy resins [75]. 
Results from the Maternal-Infant Research on Envi-
ronmental Chemicals (MIREC) study has demon-
strated that BPA levels among pregnant women do not 
appear to differ markedly from those in the general 
population [76]. It has been posited that ‘free’ BPA is 
able to cross the placenta, while glucuronidated BPA 
cannot. Thus, the maternal capacity for clearance 
depends on the maternal clearance of BPA as well as 
the fetal capacity for conjugation, which may ‘trap’ 
glucuronidated BPA in the fetal compartment and 
prolong fetal exposure [71]. In a study that focused on 
the assessment of BPA exposure and effects in fetal 
tissue, fetal liver tissue was analyzed from the Wash-
ington Birth Defects Research Laboratory Fetal Bio-
bank. Using next-generation sequencing, liver BPA 
levels were determined to be significantly associated 
with indicators of global methylation. Specifically, 
higher BPA levels were associated with greater num-
bers of hypomethylated repeat sequences, suggesting 
global hypomethylation. They also noted that, based 
on differential methylation of CpG islands, shores and 
shelves, there was an overall trend of hypomethylation 
across the genome [77]. Further research using fetal liver 
tissue has also identified specific relationships between 
BPA and repetitive DNA elements, where nonmono-
tonic relationships between BPA exposure and DNA 
methylation were observed in several repeat families, 
including LINE1 [78]. Nonmonotonic relationships 
have previously been observed in prenatal mouse expo-
sure models both with respect to both epigenomic 
and metabolic end points [79–81]. However, previous 
research, using both LUMA and pyrosequencing, did 
not identify a relationship between global methyla-
tion and BPA exposure in fetal liver or kidney, but did 
note a positive relationship between BPA exposure and 
LINE1 methylation in the placenta [82]. These results 
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suggest that indicators of global methylation, namely 
repetitive DNA elements, are associated with prenatal 
BPA exposure in a dose- and tissue-specific manner. 
It is also important to note that repeat DNA elements 
respond differentially to environmental exposures, 
therefore, changes in Alu and LINE1 may represent 
methylation changes occurring in different parts of the 
methylome [26,83].
In contrast to global methylation detailed above, 
Faulk et al. also examined genome-wide CpG meth-
ylation in relation to BPA exposure, identifying and 
validating differential methylation within the snRNA 
cluster around SNORD116, a maternally imprinted 
locus [77]. One study has tested the relationship 
between BPA exposure and miRNA expression, but no 
significant relationships were observed [37].
Dichlorodiphenyltrichloroethane
DDT is a persistent organic pollutant. While DDT was 
used extensively from the 1940s until 1973, it is no lon-
ger in commercial use in the US, although it remains in 
the environment as a legacy contaminant [84]. Dichlo-
rodiphenyldichloroethylene (DDE), a common break-
down product of DDT that may form in the environ-
ment or within the body, is often examined alongside 
DDT as it has been associated with adverse health 
outcomes in human populations [85,86]. While DDT 
and DDE both have long half-lives in the environment 
and the human body, DDE was observed to be the pre-
dominant form found in pregnant women participat-
ing in the National Health and Nutrition Examination 
Survey [87]. While levels of DDT are lower within fetal 
than maternal tissues, there is evidence that DDT is 
actively transported across the placenta as fetal levels 
are higher than expected via passive diffusion [72]. Pre-
natal exposure to DDT and DDE has been associated 
with a range of early and later life health outcomes, 
including fetal growth measures, adolescent neuro-
development, indicators of female reproductive func-
tioning, and lung functioning [88–93]. When examin-
ing the association between DDT, DDE, and global 
methylation of the fetal epigenome, results from the 
Center for Health Assessment of Mothers and Chil-
dren of Salinas (CHAMACOS) study indicate that 
maternal serum DDT and DDE levels are inversely 
associated with Alu methylation in cord blood [83]. 
However, additional research from this cohort, using 
LUMA to measure global CpG methylation, did not 
report a relationship between placental DDE levels and 
global methylation [94]. The inconsistency between 
these results originating from the same cohort sug-
gest that DDT has tissue-specific effects on the fetal 
epigenome, as was noted previously with BPA. Alter-
natively, the discrepancy may also be due to the use of 
different methods of assessing DNA methylation. As 
previously mentioned, LINE1 and Alu elements may 
be differentially impacted by environmental exposures 
and may capture changes occurring at only a portion of 
sites within the genome [26]. Thus results from LINE1 
and Alu elements may differ from LUMA methyla-
tion, which instead measures a ratio of unmethylated 
to methylated CpG sites across the genome.
In relation to DDE exposure, the CHAMACOS 
investigators have also examined placental methylation 
at CpG islands affiliated with two imprinted genes, 
IGF2 and H19. No significant associations were noted 
between placental DDE levels and methylation at these 
loci [94]. Additionally, no relationship has been found 
between exposure to DDE and placental miRNA 
expression [37].
Polybrominated diphenyl ethers
Two studies have examined fetal global methylation 
in association with exposure to PBDE, a class of com-
pounds used as flame retardants in products ranging 
from clothing to household building materials [95]. Evi-
dence suggests that there is relatively free transfer of 
PBDE across the placenta, particularly for low-bromi-
nated congeners [73]. Notably, infants and young chil-
dren have been observed to have higher body burden of 
PBDE than adults as a result of this placental transfer, 
as well as breast feeding and exposure to household 
dust [96]. Research originating from the CHAMA-
COS study assayed LINE1 and Alu methylation in 
DNA derived from cord blood. No association was 
noted between these indicators of global methylation 
and third trimester maternal blood PBDE. However, 
interactions between maternal blood PBDE and blood 
DDT and DDE were noted [83]. These results will be 
discussed in more detail, below, in the context of co-
exposures. A second study, examined placental LUMA 
methylation in correlation with placental PBDE levels. 
Here, a significantly positive relationship between pla-
cental PBDE and global methylation was observed [94]. 
Additionally, loss of imprinting at IGF2 and H19 was 
also examined in relationship to PBDE, although no 
significant results were reported [94].
In light of the immune-related effects of prenatal 
PBDE exposure, the relationship between methyla-
tion of TNF-α and PBDE exposure was investigated 
in the Boston Birth Cohort [97]. Maternal serum levels 
were significantly associated with a decrease in CpG 
methylation of the promoter region of TNF-α in DNA 
isolated from cord blood. Interestingly, this relation-
ship exhibited a threshold effect, where levels below 
approximately 5 ng/g-lipid displayed no change in 
TNF-α methylation. Above this threshold, there was 
a negative association between PBDE and CpG meth-
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ylation of TNF-α. Moreover, this effect appeared to be 
modified by the sex of the fetus, with the same pattern 
noted in females, but not males [97].
A single study has examined the relationship 
between placental PBDE levels and miRNA expres-
sion. No relationship was found with total placental 
PBDE, however, PBDE 209 was positively associated 
with miR-188–5p expression, while PBDE 99 was 
 negatively associated with let-7c expression [37].
Polychlorinated biphenyls
As with DDT, PCB are chemicals that are no longer 
in commercial production in the USA. Previously used 
widely as coolants, these chemicals persist in the envi-
ronment [98]. Research has demonstrated that PCB lev-
els are higher than expected in fetal tissues based on 
passive diffusion alone, suggesting an active transport 
mechanism across the placenta [72]. Moreover, biomon-
itoring of pregnant women suggests that serum levels 
of PCB may increase over the course of pregnancy as 
lipid stores are mobilized [99]. Results from the NCS 
did not identify a relationship between LUMA meth-
ylation in the placenta and placental PCB levels [94]. At 
a gene-specific level, no relationship was noted between 
PCB levels and methylation at the IGF2 and H19 loci, 
although an inverse relationship between H19 expres-
sion and PCB levels was reported [94]. These results 
suggest that in utero exposure to PCB may influ-
ence the expression of H19 via mechanisms that are 
i ndependent from CpG methylation.
Additional studies from the NCS examined miRNA 
expression in the placenta in relation to placental PCB 
levels. Notably, total PCB, PCB 52 and PCB 101 
were significantly positively associated with miR-1537 
expression [37].
Phthalates
Phthalates, like BPA, represent a class of ubiquitously 
used industrial compounds that are found widely in 
personal care items and household products [100–103]. 
There are numerous routes of exposure to phthalates, 
with the compounds being inhaled, ingested and der-
mally absorbed. Urinary metabolites are often used as 
indicators of exposure representing all of these pos-
sible routes, although their stability as a biomarker is 
short because phthalates are quickly metabolized and 
excreted from the body. Despite this rapid metabolism 
and excretion, phthalates are still detected in the amni-
otic fluid, indicating that it crosses the placenta and 
enters the fetal compartment [74]. However, perfusion 
studies indicate that placental transfer of phthalates 
may be slow [104]. As with BPA, the MIREC study has 
also demonstrated that phthalate levels in pregnant 
women are comparable to those measured in the gen-
eral population [76]. There are many different phthal-
ates used in industry, but several are more commonly 
detected and used in epidemiological studies. These 
include di(2-ethylhexyl) phthalate, diethyl phthalate 
and dibutyl phthalate, among others [105].
With respect to the fetal methylome, several stud-
ies have assessed the impact of prenatal exposure to 
phthalates on global methylation, gene-specific meth-
ylation and miRNA expression. Urinary levels of low-
molecular-weight (LMW) phthalate metabolites and 
a diethyl phthalate metabolite, mono-ethyl phthalate, 
have been negatively associated with Alu methylation 
in cord blood using maternal-infant dyads from the 
CHAMACOS study [106]. These results suggest global 
hypomethylation of the cord blood following phthal-
ate exposure and are supported by previous research 
originating from a Chinese cohort of pregnant women, 
which demonstrates that maternal urinary levels of 
di(2-ethylhexyl) phthalate were associated with hypo-
methylation of LINE1 in the placenta [107]. Taken 
together, these results suggest that prenatal phthalate 
exposures result in global hypomethylation of fetal 
DNA as assessed within placental tissue and cord 
blood.
Only one study was identified that examined gene-
specific methylation in relationship to prenatal phthal-
ate exposure [108]. Namely, CpG methylation of H19 
and IGF2 was examined in relationship to first-trimes-
ter maternal urinary phthalate measures. Both cumu-
lative and LMW phthalates were inversely associated 
with H19 and IGF2 methylation. These results indi-
cate a possible dysregulation of these imprinted genes 
that play a critical role in development [108].
A single study has examined the impact of in utero 
phthalate exposure and placental miRNA expression. 
Namely, maternal urinary LMW phthalates were 
significantly associated with decreased expression of 
 miR-185. However, in silico predicted downstream 
mRNA targets were not differentially expressed, 
indicating that other mechanisms contribute to gene 
e xpression [109].
Mixtures
In the environment, human populations are more 
likely to be exposed to mixtures of toxic substances, 
rather than single contaminants. Yet, few studies have 
been published that examine the effects of compound 
mixtures on the fetal epigenome, despite the fact that 
the chemicals reviewed here are often found within 
cord blood together [16,110]. Those that were identi-
fied examine interactions between compounds, such 
as DDT and PBDE, or how cumulative exposure to a 
group of varied chemicals, such as phenols, may corre-
spond to epigenomic changes in the fetus [83,109,111–113].
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Toxic metal mixtures
Among infants exposed prenatally to toxic metals, a 
single study has examined the effects of exposure to 
iAs and Hg on the fetal epigenome. While no signifi-
cant probes were identified after Bonferroni correction, 
a greater number of probes were observed with a p < 
0.0001 when considering the interaction than when 
considering Hg alone [111]. These results may indicate 
that there are relationships between exposure to toxic 
metals and the fetal epigenome that may not be identi-
fied until co-exposures are considered. More research 
into metals mixtures is warranted. For instance, while 
no studies have examined the impact of co-exposures 
to iAs and Cd on the fetal epigenome, recent research 
has identified that both contaminants significantly 
disrupt genes involved in the innate and adaptive 
immune system, particularly those involved in gluco-
corticoid signaling [114]. These results suggest that iAs 
and Cd may similarly affect immune-related pathways, 
 supporting the possibility of synergism.
Endocrine disruptor mixtures
As mentioned previously, the CHAMACOS study 
reported interactions between prenatal DDE and 
PBDE exposure [83]. When stratified based on mater-
nal serum DDE, PBDE was associated with hypo-
methylation of LINE1 in the fetus among those with 
low maternal DDE exposure. In those subjects with 
high maternal DDE exposure, PBDE levels were 
associated with LINE1 hypermethylation. The same 
relationships were noted for DDE exposure when the 
study population was stratified by PBDE levels. Nota-
bly, no associations were found between DDE, PBDE 
and LINE1 methylation until they were considered as 
co-exposures [83]. These results suggest that relation-
ships between prenatal exposures and the fetal epig-
enome may not be fully elucidated until co-exposures 
are considered and underscore the need for continued 
research into how endocrine disruptors may interact 
with one another.
A number of endocrine disruptors exhibit estrogenic 
activity, including BPA, DDT/DDE and PCB [115]. 
Total effective xenoestrogen burden (TEXB) repre-
sents a biomarker for cumulative xenoestrogen burden 
and has been used to assess co-exposures to such chem-
icals [116]. TEXB has been associated with LINE meth-
ylation in the placenta, with males displaying hypo-
methylation of LINE and Alu elements [112]. However, 
when assessing the relationship between TEXB and 
CpG methylation, no significantly  differentially 
 methylated probes were identified [113].
Lastly, in placental samples from the Harvard Epi-
genetic Birth Cohort (HEBC) and the Predictors of 
Preeclampsia Study (POPS), the sum of maternal uri-
nary phenols was significantly negatively associated 
with expression of miR-142 [109]. Cumulative exposure 
to nonparaben phenols, such as BPA and triclosan, was 
also significantly inversely associated with miR-15a-5p 
expression. Interestingly, this relationship exhibited a 
sex-dependent effect, with female infants exhibiting a 
significant negative relationship between total phenol 
exposure and miR-15–5p expression in the placenta. 
However, downstream gene expression analysis revealed 
that none of the in silico predicted mRNA targets were 
differentially expressed, nor were these miRNAs noted 
to be associated with any birth outcomes [109]. These 
results indicate that miRNA expression in the placenta 
is affected by cumulative phenol exposure, however, it 
is likely that multiple mechanisms are responsible for 
controlling downstream gene expression.
Contributions of animal models & in vitro 
experiments
The bulk of this review focuses on evidence that in 
utero exposure to toxic metals and endocrine disrup-
tors are associated with epigenomic reprogramming of 
human fetal tissues that, ultimately, provide mechanis-
tic evidence for the DOHaD hypothesis. Animal mod-
els have the potential to contribute substantially to our 
understanding of the mechanisms underlying these 
effects. First, animal models facilitate the examination 
of epigenomic changes that occur within tissues where 
disease originates, rather than accessible fetal tissues 
like the placenta or cord blood. For instance, if expo-
sure occurs following zygote formation, tissue-specific 
epigenomic changes result in susceptible tissues. How-
ever, if exposure directly impacts gametes, then whole-
organism epigenomic changes may result. Only tissues 
susceptible to these changes are thought to go on to 
develop disease during development. Thus, animal 
models may be used to examine epigenomic changes 
occurring within disease-relevant tissues in order to 
determine the role of environmentally induced repro-
gramming in disease. Moreover, they may aid in deter-
mining whether epigenomic reprogramming occurring 
in readily accessible tissues serves only as a biomarker 
of disease, or whether they may be directly related to 
disease development.
Second, animal models, along with cell lines, have 
also been crucially important in elucidating the mech-
anistic underpinnings of environmentally-induced 
epigenomic reprogramming. There is evidence for 
the ability of toxic metals and endocrine disruptors 
to impact the epigenetic machinery in several differ-
ent ways. First, endocrine disruptors and toxic metals 
have direct impacts on steroid hormones and/or ste-
roid hormone receptors, which can interact with and 
alter the activity of histone-modifying enzymes. For 
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example, in human cell lines, PCB exposure has been 
shown to modulate the activity of histone demethyl-
ases via androgen receptor binding [117]. Aside from 
direct activity on steroid hormone signaling, toxic met-
als and endocrine disruptors have also been shown to 
interact with DNA methyltransferases and ten-eleven 
translocation enzymes, which are responsible for meth-
ylating and demethylating CpG sites. For instance, Cd 
and As have been demonstrated to interact with DNA 
methyltransferases and ten-eleven translocations, alter-
ing their activity in in vitro experiments [118,119]. Much 
of this mechanistic evidence is reviewed in greater 
depth, elsewhere [120]. Additionally, some toxic met-
als and endocrine disruptors are known to interact 
with one-carbon metabolism, which produces methyl 
donors used for DNA methylation. For instance, iAs 
metabolism uses S-adenosylmethionine as a methyl 
donor [36]. Given that S-adenosylmethionine is also 
a methyl donor utilized for DNA methylation, it has 
been posited that iAs metabolism results in dysregula-
tion of DNA methylation [36]. Importantly, while these 
mechanisms describe how toxic metals and endocrine 
disruptors may impact epigenetic machinery, they do 
not explain how such exposures result in gene-specific 
patterning of epigenomic markers [9]. Instead, the tran-
scription factor occupancy theory provides an expla-
nation by positing that environmental exposures alter 
transcription factor activity, changing the availability 
of DNA to epigenetic machinery and giving rise to 
gene-specific patterning of epigenomic markers [9].
When considering the persistence of the impacts of 
in utero exposure to toxic metals and endocrine disrup-
tors, it is critical to consider the relative contribution of 
and interaction between pre- and postnatal exposures. 
As mentioned, the toxic metals and endocrine disrup-
tors reviewed here represent ubiquitous exposures. 
Therefore, it is likely that populations experiencing 
in utero exposures to toxic metals and endocrine dis-
ruptors also experience chronic exposure throughout 
the life course. Animal models represent important 
model organisms in which exposure during defined 
developmental windows can be investigated [121]. With 
respect to iAs exposure, prenatal exposure paradigms 
have been used to establish the sensitivity of the pre-
natal developmental window compared with other 
periods of exposure [122,123]. In human populations, on 
the other hand, it is often impossible to differentiate 
between prenatal and postnatal exposures and their 
contributions to health outcomes [121]. Related, animal 
models also foster research examining the transgenera-
tional impacts of exposure. As Sen et al. demonstrated, 
maternal Pb exposure may be related to DNA meth-
ylation in the blood of their grandchildren (F2), sug-
gesting that Pb impacts the germ line of a developing 
fetus [63]. However, assessing truly transgenerational 
effects is unlikely to be feasible in human populations. 
In animal models, transgenerational impacts can be 
assessed by examining epigenomic changes occurring 
in the F3 generation, following exposure during the F1 
prenatal period. While little work has been done with 
the toxic metals and endocrine disruptors reviewed 
here, exposure to a mixture of BPA and phthalates dur-
ing pregnancy in rats has been observed to induce a 
range of adverse health outcomes, including ovarian/
testis disease and obesity, in the F3 generation. Inter-
estingly, the F3 sperm also had altered DNA methyla-
tion in promoter regions previously associated with the 
onset of obesity [124].
Discussion & future perspective
There is a growing body of evidence linking in utero 
and early life exposures to both toxic metals and endo-
crine disruptors to disorders present during early life 
and emerging later in life. A mechanistic basis under-
lying the associations between these exposures and 
adverse health outcomes have often been difficult to 
elucidate. However, current research suggests that the 
epigenome may provide this critical link. With modi-
fications that are both responsive to the environment 
and may persist throughout the lifetime, epigenetics 
provides a mechanism for how environmental expo-
sures create long-lasting biological changes in cellular 
functioning. While, the epigenome plays a critical role 
throughout the human lifetime, the prenatal period 
represents an especially sensitive developmental win-
dow during which epigenetic marks are first being 
established [1]. Notably, the specific window of envi-
ronmental exposure during reproductive development 
is important in determining the effects observed [125]. 
For instance, if exposure occurs during a critical devel-
opmental period for reproductive system development, 
these tissues may be especially susceptible to epigen-
etic alterations and downstream adverse health out-
comes [126]. Additionally, if germ cells are exposed to 
toxic metals or endocrine disruptors, exposure may 
yield epigenetic reprogramming within every cell of 
the offspring [125]. Then, during development, tissues 
sensitive to the resulting epigenomic reprogramming 
may have an elevated risk for disease development. 
Moreover, if germ cells are exposed, then multi- and 
transgenerational impacts may be observed [127]. In 
other words, timing of exposure during the in utero 
period may direct whole-organism and/or tissue-spe-
cific effects of toxic metals and endocrine disruptors 
on the fetal epigenome. The importance of timing of 
exposure to toxic metals and endocrine disruptors and 
fetal epigenomic reprogramming should be further 
explored.
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Global methylation is often measured when assess-
ing the impact of environmental exposures on the 
epigenome. Much of the literature reviewed here uses 
transposable elements (i.e., LINE1 or Alu) as indica-
tors of global methylation. However, there is evidence 
that these elements respond differentially to environ-
mental exposures and in a sequence-specific manner, 
suggesting that they may represent only a specific part 
of the methylome. For instance, evidence demonstrates 
that LINE1 methylation may only represent weak CpG 
island methylation, rather than methylation occurring 
in other areas of the genome [26]. Moreover, Price et al. 
maintains that the only true measure of global meth-
ylation is total 5′-mC content and that results between 
studies should only be compared when methylation 
has been assayed using the same technique [26]. This 
creates difficulties when comparing the existing data 
on prenatal exposure to endocrine disruptors, as few 
studies have utilized the same method and little repli-
cation has been conducted. Faulk et al. has examined 
the relationship between BPA and global methyla-
tion using next-generation sequencing in two separate 
studies, with both reporting hypomethylation based 
on transposable elements or overall genomic meth-
ylation [77,78]. Additionally, with respect to maternal 
phthalate exposure, Alu hypomethylation was noted in 
cord blood, while LINE1 hypomethylation was found 
in the placenta [106,107]. Taken together, prenatal BPA 
and phthalate exposure may lead to global hypometh-
ylation and genomic instability in the fetal epigenome. 
Additionally, these results suggest that prenatal phthal-
ate exposure may have tissue-specific effects on indica-
tors of global methylation. We reviewed no other stud-
ies on endocrine disruptors that used the same method 
of assessing global methylation, and thus, we caution 
against cross-comparisons.
Unlike the literature on endocrine disruptors, 
research on toxic metals has used more consistent 
methods to measure both global and site-specific DNA 
methylation. Notably, high-throughput methods, such 
as the Illumina 450K BeadChip®, have been used 
routinely in the study of toxic metals-induced disease. 
Results from these assays facilitate gene-specific analy-
sis and better enable analysis of downstream affected 
biological pathways, shedding light on cell functions 
that may be dysregulated. For instance, studies from 
multiple Bangladeshi cohorts have identified differen-
tial methylation in genes related to juvenile diabetes, 
cancers, immunodeficiency and neurological dys-
function, among others related to iAs-associated dis-
eases [28,32,33]. Moreover, in a cross-study analysis of 
genes targeted for altered CpG methylation in infants 
with in utero contaminant exposure, many of the gene 
targets were identified as having common enriched 
transcription factor binding sites, providing evidence 
for common transcriptional controls in epigenetic 
patterning following contaminant exposures [9]. The 
identification of enriched transcription factor binding 
sites also provides further evidence for the transcrip-
tion factor occupancy theory, indicating that altered 
binding of transcription factors to DNA may result in 
patterns of gene-specific hyper- and hypomethylation 
noted  following environmental exposures [9].
Far less research has been conducted regarding the 
impacts of prenatal environmental exposures on fetal 
miRNA expression. Only four studies were identi-
fied that examined the relationship between prenatal 
exposure to metals and endocrine disruptors on fetal 
miRNA expression. However, the results reviewed 
here demonstrate their utility. For instance, prenatal 
iAs exposure was associated with 12 dysregulated miR-
NAs that were enriched for disease pathways related 
to iAs-associated disease (e.g., immune function) and 
predicted functional changes in downstream gene 
expression [38]. With respect to prenatal Pb exposure, 
dysregulated miRNAs in infants was significantly 
associated with neurobehavior-related signaling, pro-
viding further evidence for the role of epigenetics in 
Pb-induced neurodevelopmental outcomes [37,64]. 
Taken together, miRNA dysregulation has explana-
tory value when considered in the context of in utero 
exposures and research should be expanded upon. It 
is of particular importance given the observation, in 
some studies, that DNA methylation only corresponds 
to functional changes in gene expression at a subset of 
probes [8].
Exposure to toxic metals and endocrine disruptors 
is associated with sex-specific effects. For instance, in 
utero BPA exposure in females is more strongly asso-
ciated with preterm birth, BMI, obesity and body fat 
compared with males [128,129]. Likewise, much of the 
evidence reviewed here notes a sex-dependent nature of 
the relationship between such exposures and the fetal 
epigenome. Given the difficulties in elucidating the 
mechanisms underlying this phenomenon, this research 
provides evidence that there is sex-dependent cellular 
reprogramming that may later influence and/or deter-
mine the phenotypes noted in exposed populations. As 
mentioned above, in a Bangladesh-based birth cohort, 
Cd exposure in females was associated with methyla-
tion of genes enriched for pathways related to bone 
mineralization and morphology. Notably, in popula-
tions with Cd exposure, women are especially suscep-
tible to osteoporosis and bone fractures [130]. Addition-
ally, in utero Cd exposure has been inversely associated 
with femur length in females, but not males [131]. The 
mechanisms underlying these sex-dependent changes 
are unknown. However, it is possible that funda-
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Figure 1. Schematic of environmentally-induced fetal epigenomic reprogramming. Exposure to toxic metals and endocrine disruptors 
occurring during the prenatal period may result in fetal epigenomic reprogramming. The impacts of exposure on the fetal epigenome 
depend, in part, on factors such as nutrition and fetal sex. There is evidence that fetal epigenomic reprogramming is associated with 
altered disease susceptibility and may increase the incidence of adverse health outcomes in exposed populations. Finally, if germ 
cells are exposed to toxic metals and/or endocrine disruptors and undergo epigenomic reprogramming, multi- and transgenerational 
effects may be noted following prenatal exposure in the F1.
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mental differences between placentas derived from 
male or female fetuses may result in sexually dimor-
phic responses to environmental exposures [132]. It has 
recently been shown that gene-specific methylation 
differs between male and female placentas and these 
genes are enriched for immune function, transport of 
substances across the placenta, and transcription fac-
tors [133]. Further substantiating these findings, female- 
and male-derived placentas have differential expres-
sion levels of immune-related genes. Specifically, male 
placentas have enriched expression of genes related to 
inflammation and immune functioning, while female 
placentas have enriched expression of immune-regu-
lating genes [134,135]. These immunologic differences 
between male and female fetuses may result in greater 
vulnerability in male fetuses when faced with adverse 
environmental exposures in utero [132]. Additionally, 
differences in the expression of glucocorticoid receptors 
have been observed based on fetal sex, which may result 
in differential fetal susceptibility to the maternal stress 
and/or immune response following exposure to envi-
ronmental contaminants [136,137]. Together, these may 
ultimately contribute to sex-specific epigenomic repro-
gramming and health outcomes. While the mechanism 
underlying sex-dependent epigenetic reprogramming 
remains unknown, these results demonstrate the prom-
ise of using epigenetics to further understand the sex-
dependent effects of  environmentally induced diseases.
Interactions between these environmental expo-
sures and genomic imprinting has also been explored 
in several studies. As mentioned above, LaRocca et al. 
found that maternal phthalate exposure was associ-
ated with methylation of the promoter regions of both 
IGF2 and H19, imprinted genes with roles in both 
pre- and postnatal development and cancer [138–140]. 
Likewise, results from iAs- and/or Cd-exposed infants 
reveals differential methylation of several imprinted 
genes, including KCNQ1, PEG3, and PLAG1 [8,47]. 
Interestingly, it has been shown that methylation at 
imprinted loci are stable across a wide range of human 
tissues in infants, suggesting that the observed changes 
in imprinted genes may be representative of changes 
occurring throughout the fetus [141]. The ability for 
such exposures to alter genomic imprinting is con-
cerning given the tight regulation of imprinting dur-
ing development and the impact that the expression 
of imprinted genes has on health throughout the lifes-
pan [142]. Thus, the relationships between heavy met-
als, endocrine disruptors and methylation of imprinted 
genes should be further examined.
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As discussed above, humans are exposed to multi-
contaminant mixtures, including metals and endocrine 
disruptors. In support of this, these compounds have 
been identified in cord blood together [16,110]. Thus, 
research focusing on exposure to a single contaminant 
does not adequately represent the true human experi-
ence. Notably, Huen et al. did not identify a relation-
ship between DNA methylation and exposures to sin-
gle classes of persistent organic pollutants. However, 
when considered together, significant relationships 
between exposure to DDT/DDE, PBDE and LINE1 
methylation emerged [106]. These results indicate that 
the impact of environmental exposures on the epig-
enome may depend on simultaneous exposures, under-
scoring the need for continued research into mixtures. 
Additionally, it is important to point out that while 
described as two separate classes of contaminants in 
this review, toxic metals and endocrine disruptors are 
not mutually exclusive. Several toxic metals, includ-
ing iAs, Cd, Pb and Hg have complex modes of action 
that include endocrine disrupting effects [70]. Despite 
the overlaps between these toxic metals and endocrine 
disruptors, no studies were identified that examined 
co-exposure to metals and endocrine disruptors.
In addition to considering co-exposures, another 
important factor underlying epigenomic reprogram-
ming is nutritional status. Imbalances in micronutrients 
involved in one-carbon metabolism have been tied to 
dysregulated CpG methylation, resulting from their role 
as methyl donors [143]. In line with these observations, 
maternal nutrition also has a significant impact on the 
fetal epigenome, as well as developmental outcomes in 
offspring [144]. The relationship between micronutri-
ents, environmental exposures and epigenomic repro-
gramming has been well-documented with respect to 
iAs exposure in human populations. For instance, in 
Executive summary
Background
•	 There are three major epigenetic modifications including: DNA (CpG) methylation, microRNA expression and 
histone modifications.
•	 The fetal epigenome is impacted by environmental exposures, including toxic metals and endocrine 
disruptors.
Toxic metals
•	 Prenatal exposure to arsenic, cadmium, lead and mercury is associated with epigenomic alterations in the 
offspring.
•	 The epigenetic changes resulting from in utero toxic metal exposure are associated with functional changes in 
gene expression, birth outcomes and later life health outcomes.
Endocrine disruptors
•	 Exposure to bisphenol-a, dichlorodiphenyltrichloroethane, polybrominated diphenyl ethers, polychlorinated 
biphenyls and phthalates is associated with epigenetic changes in the offspring.
•	 Exposure to endocrine disruptors has been investigated with respect to global methylation, with tissue-
specific effects identified. Less research is available with respect to gene-specific CpG methylation and miRNA 
expression.
Co-exposures/mixtures
•	 In human populations, exposures are likely to occur in mixtures.
•	 Relationships between exposure and the fetal epigenome may not be fully elucidated until mixtures are 
considered.
•	 Few studies have examined the effects of co-exposures to metals and/or endocrine disruptors on the fetal 
epigenome and further research is needed.
Contributions of animal models & in vitro experiments
•	 Animal models provide an important tool for discerning between the contributions of pre- and postnatal 
exposure to toxic metals and endocrine disruptors to epigenomic reprogramming.
•	 Animal models allow for assessment of target tissues and serve as model organisms in which transgenerational 
impacts of environmental exposures can be more readily examined.
•	 Animal models and in vitro experiments enable examination of mechanistic underpinnings of epigenomic 
reprogramming induced by exposure to toxic metals and endocrine disruption.
Conclusion & future perspective
•	 Prenatal exposures to toxic metals and endocrine disruptors are associated with birth outcomes and later life 
health effects.
•	 Exposure-induced epigenetic changes may underlie these effects as these compounds have been associated 
with changes to global methylation, CpG methylation and miRNA expression.
•	 Uncertainties remain about the mechanistic linkage between epigenetic changes observed in fetal tissues and 
adverse outcomes that may develop in distinct tissues.
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populations with chronic iAs exposure, nutrition is a sig-
nificant modifier of the relationship between exposure, 
epigenomic reprogramming, and health outcomes [145–
147]. Importantly, folate supplementation has also been 
observed to reduce levels of more harmful arsenical 
species, indicating its potential as an intervention to 
mitigate the harms of iAs exposure [148]. Relationships 
between exposure to nutritional factors, such as folate 
and Vitamin D, have also been observed with respect 
to endocrine disruptors [149,150]. These relationships sug-
gest that such nutritional factors may also modify the 
relationship between exposure to other toxic metals, 
endocrine disruptors and epigenomic reprogramming. 
This complicates the relationship between exposure to 
toxic metals, endocrine disruptors and the fetal epig-
enome and the ability to disentangle these effects. How-
ever, it also demonstrates that nutrition is an impor-
tant factor to consider when studying the relationship 
between toxic metals, endocrine disruptors and the fetal 
epigenome. Moreover, it is especially important to con-
sider when generalizing these results across populations. 
Changes to the epigenome provide an explanation for 
the persistent health effects that are observed following 
in utero exposures to environmental contaminants, such 
as toxic metals and endocrine disruptors. The research 
reviewed here demonstrates that the fetal epigenome 
displays changes associated with such exposures and 
is summarized in Figure 1. Some of these changes have 
also been associated with dysregulated downstream 
signaling and adverse birth outcomes, demonstrating 
the link between environmentally induced epigenetic 
reprogramming and adverse outcomes. However, ques-
tions remain about the functional consequences of these 
observations. Only a few studies reviewed here examined 
the relationship between differentially regulated epigen-
etic marks and downstream gene expression. Moreover, 
further research is needed to determine how CpG meth-
ylation and/or miRNA expression within the placenta 
or cord blood relate to disorders emerging within sepa-
rate tissues. More work is needed to strengthen the links 
between exposure-associated epigenomic changes and 
adverse health outcomes.
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